D-1226-2014 Class III Terminated
FDA drug recall D-1226-2014 was initiated by Hospira Inc. on Mar 25, 2014 and is designated Class III. Reason for recall: Labeling; Missing label; ampoules are missing the immediate container label The recall status is terminated (terminated Dec 18, 2015). Affected quantity: 237,850 ampoules.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 16, 2014
- Initiation Date
- Mar 25, 2014
- Termination Date
- Dec 18, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 237,850 ampoules
Product Description
Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.
Reason for Recall
Labeling; Missing label; ampoules are missing the immediate container label
Distribution Pattern
Nationwide
Code Information
Lot: 221303A, 1OCT2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1226-2014
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026